Parameters | Value ($) | Range | Resource | Distribution |
---|---|---|---|---|
Nivolumab (100Â mg) | 1342.11 (China) | 1073.69-1610.53 | Local estimate | Gamma |
3290.22 (US) | 2632.18-3948.26 | RED BOOK | Gamma | |
Nivolumab (40Â mg) | 665.40 (China) | 532.32-798.48 | Local estimate | Gamma |
1316.09 (US) | 1052.87-1579.31 | RED BOOK | Gamma | |
Oxaliplatin (50Â mg) | 164.50 (China) | 131.60-197.40 | Local estimate | Gamma |
98.88(US) | 79.10-118.66 | RED BOOK | Gamma | |
Capecitabine (500 mg) | 1.76 (China) | 1.41–2.11 | Local estimate | Gamma |
37.71 (US) | 30.17–45.25 | RED BOOK | Gamma | |
5-Fu (250 mg) | 7.61 (China) | 6.09–9.13 | Local estimate | Gamma |
59.85 (US) | 47.88–71.82 | RED BOOK | Gamma | |
Leucovorin (100 mg) | 2.22 (China) | 1.78–2.66 | Local estimate | Gamma |
22.8 (US) | 18.24–27.36 | RED BOOK | Gamma | |
Paclitaxel (30 mg) | 59.25 (China) | 47.40–71.10 | Local estimate | Gamma |
20.16 (US) | 16.13–24.19 | RED BOOK | Gamma | |
Docetaxel (20Â mg) | 162.18 (China) | 129.74-194.62 | Local estimate | Gamma |
211.14 (US) | 168.91-253.37 | RED BOOK | Gamma | |
Carboplatin (50 mg) | 4.40 (China) | 3.52–5.28 | Local estimate | Gamma |
12.29 (US) | 9.83–14.75 | RED BOOK | Gamma | |
Cisplatin (30 mg) | 2.78 (China) | 2.22–3.34 | Local estimate | Gamma |
21.20 (US) | 16.96–25.44 | RED BOOK | Gamma | |
Ramucirumab (100Â mg) | - | Â | Local estimate | Gamma |
1427.58 (US) | 1142.06-1713.10 | RED BOOK | Gamma | |
Perbrolizumab (100Â mg) | 2596.96 (China) | 2077.57-3116.35 | Local estimate | Gamma |
5834.45 (US) | 4667.56-7001.34 | RED BOOK | Gamma | |
Toripalimab (2400Â mg) | 304. 51 (China) | 243.61-365.41 | Local estimate | Gamma |
- | - | RED BOOK | Gamma | |
Atezolizumab (1200Â mg) | 4753.90 (China) | 3803.12-5704.68 | Local estimate | Gamma |
11032.84 (US) | 8826.27-13239.41 | RED BOOK | Gamma | |
Ipilimumab (50Â mg) | 4058.21 (China) | 3246.57-4869.85 | Local estimate | Gamma |
9273.77 (US) | 7419.02-11128.52 | RED BOOK | Gamma | |
Laboratory tests | 28.99 (China) | 23.19–34.79 | Local estimate | Gamma |
315 (US) | 252–378 | [17] | Gamma | |
CT | 289.73 (China) | 231.78-347.68 | Local estimate | Gamma |
231 (US) | 184.8-277.2 | [17] | Gamma | |
Anemia | 508.2 (China) | 406.56-609.84 | [15] | Gamma |
4368 (US) | 3494.4-5241.6 | [19] | Gamma | |
Neutropenia | 466 (China) | 372.8-559.2 | [15] | Gamma |
5937 (US) | 4749.6-7124.4 | [18] | Gamma | |
Neutrophil count decreased | 534.4 (China) | 427.52-641.28 | [16] | Gamma |
5937 (US) | 4749.6-7124.4 | [18] | Gamma | |
Cost of supportive care per cycle | 117 (China) | 93.6-140.4 | [17] | Gamma |
3049 (US) | 2439.2-3658.8 | [17] | Gamma | |
Routine follow-up of patients per unit | 51.5 (China) | 41.2–61.8 | [17] | Gamma |
422 (US) | 337.6-506.4 | [19] | Gamma |